Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Let it fall? study tests if letting catheters drop out on their own is better than nurse removal

NCT ID NCT05313945

Symptom relief Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether letting a bladder catheter fall out on its own (passive removal) is better than having a nurse pull it out (active removal) after urological surgery. 160 men will be randomly assigned to one method. Researchers will measure satisfaction, pain, and anxiety. The goal is to find which approach is more comfortable for patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Procedure: passive catheter removal vs active removal by nurse
What this could lead to
If passive removal works better, it could become a standard, less painful way to remove catheters after urological surgery.
What could go wrong
This is a small, early-stage trial (160 men) and results may not apply to all patients or surgeries. The difference between methods might be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2022

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male ≥ 18 years old 2. With an indwelling urinary catheter placed after any of the following procedures: A uro-endoscopic surgery from the list below: * Endoscopic prostate resection (or transurethral prostate resection). * Laser prostate enucleation * Prostate thermotherapy by radiofrequency * A high-intensity focused ultrasound treatment for prostate cancer * Cervico-prostatic incision or internal urethrotomy * Endoscopic/Transurethral Resection of Bladder Tumor (TURBT) * Surgical treatment of bladder stones, ureter stones (rigid ureteroscopy) and kidney stones (flexible ureteroscopy with laser stone fragmentation) 3. Patient who has given written consent to participate Exclusion Criteria: 1. Patient who is unable to perform intimate hygiene alone in a standing position 2. Patient with a painful genital lesion 3. Patient with an extended pelvic pathology 4. Need to remove the indwelling urinary catheter at the patient's home instead of hospital 5. Patient under guardianship or curator 6. Patient unable to understand the objectives of the study or unwilling to comply with postoperative instructions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urologic diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

urinary system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urologic diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Grenoble

    RECRUITING

    Grenoble, 38000, France

  • Hôpita Edouard Herriot

    RECRUITING

    Lyon, 69003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.